SCHEMBL7209239

SCHEMBL7209239

O=C(Nc1ccc(Br)cc1)c1cc(Br)ccc1NS(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC10A6 Q3KNW5 2/20 0.71
SLC10A2 Q12908 1/20 0.71
SLC10A1 Q14973 1/20 0.71
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
HPGD P15428 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
GPR27 Q9NS67 4/20 0.53
AVPR2 P30518 1/20 0.53
METAP2 P50579 2/20 0.51
MAPT P10636 1/20 0.47
POLB P06746 1/20 0.46
KDM1A O60341 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7116008 0.91 SLC10A6 (0.85) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7208184 0.85 SLC10A6 (0.76) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7126120 0.85 SLC10A6 (0.98) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7120319 0.84 SLC10A6 (0.76) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL6756862 0.83 SLC10A6 (1.00) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7213023 0.83 SLC10A6 (0.73) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7213164 0.82 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7120427 0.82 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7128123 0.82 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7627121 0.82 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1GPR27AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP disclosed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO disclosed